Literature DB >> 1848356

Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene.

F H Burton1, K W Hasel, F E Bloom, J G Sutcliffe.   

Abstract

Cyclic AMP is thought to act as an intracellular second messenger, mediating the physiological response of many cell types to extracellular signals. In the pituitary, growth hormone (GH)-producing cells (somatotrophs) proliferate and produce GH in response to hypothalamic GH-releasing factor, which binds a receptor that stimulates Gs protein activation of adenylyl cyclase. We have now determined whether somatotroph proliferation and GH production are stimulated by cAMP alone, or require concurrent, non-Gs-mediated induction of other regulatory molecules by designing a transgene to induce chronic supraphysiological concentrations of cAMP in somatotrophs. The rat GH promoter was used to express an intracellular form of cholera toxin, a non-cytotoxic and irreversible activator of Gs. Introduction of this transgene into mice caused gigantism, elevated serum GH levels, somatotroph proliferation and pituitary hyperplasia. These results support the direct triggering of these events by cAMP, and illustrate the utility of cholera toxin transgenes as a tool for physiological engineering.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848356     DOI: 10.1038/350074a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  33 in total

Review 1.  Aspects of anterior pituitary growth, with special reference to corticotrophs.

Authors:  A M McNicol; E Carbajo-Perez
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

Review 2.  PRKAR1A and the evolution of pituitary tumors.

Authors:  Lawrence S Kirschner
Journal:  Mol Cell Endocrinol       Date:  2010-05-06       Impact factor: 4.102

Review 3.  Mitogenic pathways regulated by G protein oncogenes.

Authors:  S K Gupta; C Gallego; G L Johnson
Journal:  Mol Biol Cell       Date:  1992-01       Impact factor: 4.138

4.  Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities.

Authors:  Salahaldin A Tahir; Jianjun Gao; Yuji Miura; Jorge Blando; Rebecca S S Tidwell; Hao Zhao; Sumit K Subudhi; Hussein Tawbi; Emily Keung; Jennifer Wargo; James P Allison; Padmanee Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

5.  Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome.

Authors:  W F Schwindinger; C A Francomano; M A Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 6.  Clinical implications of growth hormone-secreting tumor subtypes.

Authors:  Katja Kiseljak-Vassiliades; Shibana Shafi; Janice M Kerr; Tzu L Phang; B K Kleinschmidt-DeMasters; Margaret E Wierman
Journal:  Endocrine       Date:  2012-03-21       Impact factor: 3.633

7.  Correlation between prolactin secretion and Gs protein expression during sustained cholera-toxin stimulation.

Authors:  J H Lin; H Y Wang; J C Fong; J T Pan; F F Wang
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

8.  OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons.

Authors:  K M Campbell; L de Lecea; D M Severynse; M G Caron; M J McGrath; S B Sparber; L Y Sun; F H Burton
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

9.  The inhibitory guanine nucleotide-binding protein Gi2alpha induces and potentiates adipocyte differentiation.

Authors:  K E Høvik; P Wu; J O Gordeladze
Journal:  Lipids       Date:  1999-04       Impact factor: 1.880

10.  Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells.

Authors:  Philip Zeitler; Gamini Siriwardana
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.